By Amber Deter The Forma Therapeutics IPO launched on the Nasdaq market. It hit less than a month after the company filed with the SEC. As biotech companies successfully go public, Forma Therapeutics stock could be the next hit.
But is it a good investment opportunity? Here’s what we know…
Forma Therapeutics IPO: The Business
Forma Therapeutics is a biopharmaceutical company. It aims to develop and commercialize novel therapeutics to help patients with rare hematologic diseases and cancers. The company’s focus is sickle cell disease (SCD) and prostate cancer.
In 2019, Forma reorganized, filing from a limited liability company to a corporation. The company also named Frank …read more
